Chronic Plaque Psoriasis Market Size is to Show Remarkable Growth Trends from 2024 to 2034, estimates DelveInsight

AI Briefing

• – Chronic Plaque Psoriasis market to show remarkable growth, expected to reach $24.8 billion by 2034, driven by increasing awareness and treatment options.
• – The US will have the largest market share, accounting for 44.1% of the global market, followed by EU4 countries.
• – Key players like Janssen Pharmaceuticals, Eli Lilly and Company, and AbbVie will dominate the market, with new treatments like secukinumab and risankizumab driving growth.